Molecular evidence on the occurrence of co-infection with Pichia guilliermondii and Wuchereria bancrofti in two filarial endemic districts of India

Infectious Diseases of Poverty

Volumn 3, Issue 1, 2014, Pages

  Mukherjee, Suprabhat ^a   Mukherjee, Niladri ^a   Saini, Prasanta ^a   Gayen, Prajna ^a   Roy, Priya ^a   Sinha Babu, Santi P ^a  

^a VISVA BHARATI UNIVERSITY   (India)

Author keywords

Co infection; Lymphatic filariasis; Molecular identification; Pichia guilliermondii; Polymerase chain reaction

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CYCLOHEXIMIDE; GRISEOFULVIN; NIKKOMYCIN; NYSTATIN; TERBINAFINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BANCROFTIAN FILARIASIS; BLOOD SAMPLING; DNA ISOLATION; DNA SEQUENCE; FEMALE; FUNGUS ISOLATION; HUMAN; INDIA; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MEYEROZYMA GUILLIERMONDII; MIXED INFECTION; MYCOSIS; NONHUMAN; PATHOGENICITY; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SEQUENCE ANALYSIS; WUCHERERIA BANCROFTI;

EID: 84906217865     PISSN: 20955162     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/2049-9957-3-13     Document Type: Article

References (45)

1. Behm CA, Bendig MM, McCarter JP, Sluder AE. WHO Report - WHO/TDR Scientific Working Group on 'RNA interference as a means of identifying drug targets for filariasis' 2003, 1-15. Geneva, Switzerland: WHO.
2. Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010, 376:1175-1185. 10.1016/S0140-6736(10)60586-7, 20739055.
3. Sabesan S, Vanamail P, Raju K, Jambulingam P. Lymphatic filariasis in India: epidemiology and control measures. J Postgrad Med 2010, 56:232-238. 10.4103/0022-3859.68650, 20739779.
4. Dreyer G, Norões J, Figueredo-Silva J, Piessens WF. Pathogenesis of Lymphatic Disease in Bancroftian Filariasis: A Clinical Perspective. Parasitol Today 2000, 16:544-548. 10.1016/S0169-4758(00)01778-6, 11121854.
5. Fernando RJ, Fernando SSE, Leong ASY. Tropical infectious diseases: epidemiology, investigation, diagnosis and management 2001, Cambridge: Cambridge University Press.
6. Armstrong D. History of opportunistic infection in the immunocompromised host, controversies in the management of infections in immunocompromised patients. Clin Infect Dis 1993, 17:318-321.
7. Pasquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, Flores J, Benito C, Redondo C, Lacruz J, Abril V, Onofre J, Leishmania HIV, . Mediterreanean Co-operative Group Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a mediterreanean region. Eur J Clin Microbiol Infect Dis 2005, 24:411-418. 10.1007/s10096-005-1342-6, 15928908, Mediterreanean Co-operative Group.
8. Richardson MD. Opportunistic and pathogenic fungi. J Antimicrob Chemother 1991, 28:1-11.
9. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011, 11:142-151. 10.1016/S1473-3099(10)70218-8, 21272794.
10. Pasqualotto AC, Antunes AGV, Severo LC. Candida guilliermondii as the aetiology of candidosis. Rev Inst Med Trop S Paulo 2006, 48:123-127. 10.1590/S0036-46652006000300002, 16847499.
11. Martini AV, Kurtzman CP, Meyer SA, O'Neill EB. Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov. FEMS Yeast Res 2005, 5:463-469. 10.1016/j.femsyr.2004.10.008, 15691751.
12. Pang SYM, Tristram S, Brown S. The Contribution of Growth Rate to the Pathogenicity of Candida spp. Int J Biol Life Sci 2012, 8:80-86.
13. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002, 50:243-260. 10.1053/jhin.2001.1151, 12014897.
14. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703. 10.1086/599039, 19441981.
15. Dick JD, Merz WG, Saral R. Incidence of polyene resistant yeast recovered from clinical specimens. Antimicrob Agents Chemother 1980, 18:158-163. 10.1128/AAC.18.1.158, 283956, 7416742.
16. Lee GW, Kim TH, Son JH. Primary Candida guilliermondii infection of the knee in a patient without predisposing Factors. Case Report Med 2012, 2012:375682.
17. Pfaller MA, Diekema DJ, Mendez M, Kibbler C, Erzsebet P, Chang SC, Gibbs DL, Newell VA. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol 2006, 44:3551-3556. 10.1128/JCM.00865-06, 1594787, 17021081.
18. Ormerod AD, Petersen J, Hussey JK, Weir J, Edward N. Immune complex glomerulonephritis and chronic anaerobic urinary infection-complications of filariasis. Postgrad Med J 1983, 59:730-733. 10.1136/pgmj.59.697.730, 2417673, 6227878.
19. Date A, Chandy M, Pulimood BM. Filarial chyluria with opportunistic infections. Trans R Soc Trop Med Hyg 1983, 77:112-113. 10.1016/0035-9203(83)90032-9, 6344355.
20. Metenou S, Babu S, Nutman TB. Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS 2012, 7:231-238. 10.1097/COH.0b013e3283522c3d, 3431797, 22418448.
21. Pani SP, Srividya A. Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading. Indian J Med Res 1995, 102:114-118.
22. Gayen P, Maitra S, Datta S, Sinha Babu SP. Evidence for Wolbachia symbiosis in microfilariae of Wuchereria bancrofti from West Bengal. J Biosci 2010, 35:73-77. 10.1007/s12038-010-0009-3, 20413911.
23. Gayen P, Nayak A, Saini P, Mukherjee N, Maitra S, Sarkar P, Sinha Babu SP. A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India. Acta Trop 2013, 125:150-156. 10.1016/j.actatropica.2012.10.011, 23123345.
24. Martinez JM, Gomez EV, Peman J, Canton E, Garcia MG, Del Castillo Agudo L. Identification of pathogenic yeast species by polymerase chain reaction amplification of the RPS0 gene intron fragment. J Appl Microbiol 2010, 108:1917-1927.
25. Smith HL, Rajan TV. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro. Exp Parasitol 2000, 95:265-270. 10.1006/expr.2000.4525, 11038309.
26. Bazzocchi C, Ceciliani F, McCall JW, Ricci I, Genchi C, Bandi C. Antigenic role of the endosymbionts of filarial nematodes: IgG response against the Wolbachia surface protein in cats infected with Dirofilaria immitis. Proc Biol Sci 2000, 267:2511-2525. 10.1098/rspb.2000.1313, 1690852, 11197127.
27. O'Donnell K. Fusarium and its near relatives. The Fungal Holomorph: Mitotic, Meiotic and Pleomorphic Speciation in Fungal Systematics 1993, 225-233. Wallingford: CAB International, Reynolds DR, Taylor JW.
28. Lee SB, Taylor JW. PCR protocols: A Guide to Methods and Applications. Isolation of DNA from fungal mycelia and single spores 1990, 282-287. Orlando, Florida: Academic Press, Innis MA, Gelfand DH, Sninsky JJ, White TJ.
29. Porter TM, Golding GB. Factors that affect large subunit ribosomal DNA amplicon sequencing studies of fungal communities: classification method, primer choice, and error. PLoS ONE 2012, 7:e35749. 10.1371/journal.pone.0035749, 3338786, 22558215.
30. Thompson JD. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680. 10.1093/nar/22.22.4673, 308517, 7984417.
31. Nei M, Kumar S. Molecular Evolution and Phylogenetics 2000, New York: Oxford University Press.
32. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
33. Hayat MA. Principles and Techniques of Electron Microscopy: Biological Applications 2000, Cambridge: Cambridge University Press.
34. Clinical and Laboratory Standard Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2006, Wayne: Clinical and Laboratory Standard Institute, Clinical and Laboratory Standard Institute.
35. Hillis DM, Bull JJ. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol 1993, 42:182-192.
36. Beresa C, De Nazaréa FV, De Souzaa NC, Miguel MA, Werneck MM. Tapered plastic optical fiber-based biosensor - tests and application. Biosens Bioelectron 2011, 30:328-332.
37. Zullo BA, Cioccia G, Ciafardini G. Distribution of dimorphic yeast species in commercial extra virgin olive oil. Food Microbiol 2010, 27:1035-1042. 10.1016/j.fm.2010.07.005, 20832682.
38. Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, Tiraboshi N, Nagy E, Gibbs DL. Results from the ARTEMIS DISK global antifungal surveillance study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005, 43:5848-5859. 10.1128/JCM.43.12.5848-5859.2005, 1317207, 16333066.
39. Babu S, Anuradha R, Kumar NP, George PJ, Kumaraswami V, Nutman TB. Toll- like receptor-and filarial antigen-mediated, mitogen-activated protein kinase-and NF-κB dependent regulation of angiogenic growth factors in filarial lymphatic pathology. Infect Immun 2012, 80:2509-2518. 10.1128/IAI.06179-11, 3416485, 22508858.
40. Figueredo-Silva J, Noroes J, Cedenho A, Dreyer G. The histo-pathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease. Ann Trop Med Parasitol 2002, 96:531-541. 10.1179/000349802125001348, 12396316.
41. Taylor MJ. Wolbachia in the inflammatory pathogenesis of human filariasis. Ann NY Acad Sci 2003, 990:444-449. 10.1111/j.1749-6632.2003.tb07409.x, 12860672.
42. Kurtzman CP, Fell JW, Boekhout T. The yeasts: a taxonomic study 2011, New York: Elsevier.
43. Linton CJ, Borman AM, Cheung G, Holmes AD, Szekely A, Palmer MD, Bridge PD, Campbell CK, Johnson EM. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom mycology reference laboratory. J Clin Microbiol 2007, 45:1152-1158. 10.1128/JCM.02061-06, 1865856, 17251397.
44. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, Limaye AP, Cookson BT. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 2001, 39:4042-4051. 10.1128/JCM.39.11.4042-4051.2001, 88485, 11682528.
45. Del Pilar VM, Garcia Martínez JM, Canton E, Peman J, Gomez Garcia MM, Gomez EV, Del Castillo AL. Differentiation of Candida parapsilosis, C. orthopsilosis and C. metapsilosis by specific PCR amplification of the RPS0 intron. Int J Med Microbiol 2011, 301:531-535. 10.1016/j.ijmm.2011.02.001, 21570908.